Atinvicitinib

Product Specifications

CAS Number

2169273-59-8

Target

JAK

Related Pathways

JAK/STAT signaling|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Stem Cells

Purity

0.9936

Bioactivity

Atinvicitinib, a selective Janus kinase (JAK) inhibitor, demonstrates high specificity for Janus kinase 1 (JAK1), consequently inhibiting downstream cytokine signaling pathways that rely on JAK1 enzymatic activity. Atinvicitinib modulates a wide range of cytokines that are implicated in itch responses, allergic reactions, and inflammatory conditions, making it a significant research tool for studying cytokine-mediated immune processes as well as therapeutic modulation of allergic and inflammatory diseases.